FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:1212 April 15, 1999 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: Ticlopidine is used extensively for patients who undergo coronary angioplasty, stent deployment, or both. Most physicians are well aware of its potential side effects, such as diarrhea, neutropenia, or rash. We describe a case in which ticlopidine caused the unusual complication of toxic erythroderma.

A 65-year-old man presented with coronary ischemia due to high-grade stenosis of the proximal left anterior descending coronary artery. He was advised to undergo percutaneous coronary intervention. Ticlopidine (500 mg) was started one day before the procedure. The deployment of the stent was successful, and the patient received two more doses of ticlopidine, . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.